Tomoyasu Chihiro, Kikuchi Ken, Kaneda Daisuke, Yagyu Shigeki, Miyachi Mitsuru, Tsuchiya Kunihiko, Iehara Tomoko, Sakai Toshiyuki, Hosoi Hajime
Department of Pediatrics, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto 602‑8566, Japan.
Department of Molecular‑Targeting Cancer Prevention, Kyoto Prefectural University of Medicine, Kyoto 602‑8566, Japan.
Oncol Rep. 2019 Apr;41(4):2601. doi: 10.3892/or.2019.6997. Epub 2019 Feb 1.
Subsequent to the publication of the above article, the authors have realized that errors were introduced into Fig. 4 at the typesetting stage. Essentially, in Fig. 4B, the P‑value should have read as "P=0.13" (not as 0.013), and in Fig 4D, the labels for OBP- and OBP+ were set the wrong way around. The correct version of Fig. 4, as originally submitted, is shown opposite. The Editor apologizes to the authors for introducing these errors into their figure, and to the readership for any inconvenience caused. [the original article was published in Oncology Reports 41: 643-649, 2019; DOI: 10.3892/or.2018.6813.
上述文章发表后,作者们意识到在排版阶段图4出现了错误。实质上,在图4B中,P值应为“P = 0.13”(而非0.013),并且在图4D中,OBP-和OBP+的标签设置反了。最初提交的图4的正确版本见对面。编辑就图中出现这些错误向作者致歉,并就给读者带来的不便表示歉意。[原文发表于《肿瘤学报道》41: 643 - 649, 2019;DOI: 10.3892/or.2018.6813]